Click on image to view larger version.

Figure 1 Study protocol. Subjects were randomized to either placebo, L-arginine (7 g twice daily), atorvastatin (40 mg/day) or combination therapy. Vascular function was assessed noninvasively at baseline and after six weeks of treatment.